Losing Over 50 POUNDS With GLP-1 Agonists

About this video

Derek compares the main GLP-1 agonists — semaglutide, liraglutide, and dulaglutide — weighing trial efficacy against tolerability and how long each stays active in the body. He argues semaglutide looks strongest on paper for weight loss and blood-sugar control, but relays anecdotes from peers who found it caused severe nausea, while others found it suppressed appetite even against strong hunger signals. His own early experience, he admits, was underwhelming and highly individual. Mechanistically, he explains the class through slowed gastric emptying, increased insulin secretion, and suppressed glucagon, stressing the weight loss is simply reduced intake, not direct fat burning. He notes his clinic, Marek Health, offers access to these medications under medical oversight.

Key takeaways

• Derek argues individual tolerability can matter more than which GLP-1 ranks first in trials
• A longer-acting drug is harder to escape if side effects hit, he cautions
• He frames dramatic trial results in people with obesity as evidence appetite, not willpower failure, drives intake
• GLP-1 weight loss is reduced eating from satiety signaling, not a direct fat-burning effect
• He criticizes bodybuilding coaches who dismiss newer drug classes without studying them

Episode details: published July 2, 2021 · 139.5K views · 20:55 long. Summary written by Self Growth Videos from the episode itself. The concepts described are Derek’s (More Plates More Dates), presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Derek co-founded Marek Health and Gorilla Mind, businesses that sell into the topics he teaches; Self Growth Videos reproduces none of his codes.

← Previous: The ULTIMATE Fat Loss Drug? | 33 POUND AVERAGE WEIGHT LOSS | Gila Monster Venom · Next: Peptides & UGL Gear →

All Derek (More Plates More Dates) videos · Derek (More Plates More Dates) profile · More Plates More Dates on YouTube